NCT06691438

Brief Summary

The primary objective of the study is to prospectively compare perioperative pain assessed in patients undergoing targeted prostate biopsies, either transrectally or transperineally, under local anesthesia with or without a virtual reality hypnosis headset. The study was sized based on a mean pain reduction of 1.5 points on a numerical scale (0-10 NAS), with an estimate of procedure-related pain of 4.0 on the NAS scale.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Dec 2024Oct 2026

First Submitted

Initial submission to the registry

October 21, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

November 15, 2024

Completed
16 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

November 15, 2024

Status Verified

October 1, 2024

Enrollment Period

1.8 years

First QC Date

October 21, 2024

Last Update Submit

November 14, 2024

Conditions

Keywords

SedationPainHypnosisVirtual Reality

Outcome Measures

Primary Outcomes (1)

  • To prospectively compare perioperative pain assessed in patients undergoing targeted prostate biopsies, transrectally or transperineally, under local anesthesia with or without a virtual reality hypnosis headset.

    maximum pain felt during the procedure on a numerical EN scale, ranging from 0 (no pain) to 10 (extreme pain). The values will be collected directly at the end of the procedure.

    after the procedure

Secondary Outcomes (12)

  • Pain after the procedure

    when leaving the hospital

  • Stress during the procedure

    after the procedure

  • Immersion during hypnosis

    at the procedure

  • Evaluation of the nociceptive response to painful stimuli

    during the procedure

  • Satisfaction with the procedure

    after the procedure

  • +7 more secondary outcomes

Study Arms (2)

prostate biopsies without virtual reality hypnosis headset

ACTIVE COMPARATOR

Biopsies are performed according to current recommendations

Device: prostate biopsy

prostate biopsies with virtual reality hypnosis headset

EXPERIMENTAL

Patient wearing a virtual reality headset put in place in the transfer room 15 minutes before the procedure and maintained throughout the procedure.

Device: prostate biopsy

Interventions

prostate biopsies with virtual reality hypnosis headset

Also known as: experimental
prostate biopsies with virtual reality hypnosis headsetprostate biopsies without virtual reality hypnosis headset

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients who are candidates for ultrasound-guided prostate biopsies under local anesthesia, via transperineal or transrectal route
  • Patient having signed informed consent

You may not qualify if:

  • Patient suffering from blindness or any other visual handicap that contraindicates the use of the headset
  • Deaf or hard of hearing patients
  • Patients suffering from epilepsy and/or mental deficiency, and/or disorders of higher functions
  • Psychotic patients
  • Claustrophobic patients or those who cannot tolerate a mask over their eyes
  • Refusal of local anesthesia
  • Protected person (art. L1121-5 to L1121-8 of the CSP)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Grenoble

Grenoble, 38043, France

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gaelle GF FIARD, professor

    university grenoble hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gaelle GF FIARD, Professor

CONTACT

Assilah AB BOUZIT, study co

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The maximum value of the pain will be collected by the research associate or the coordinating nurse who will be blinded to the randomization arm
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professeur

Study Record Dates

First Submitted

October 21, 2024

First Posted

November 15, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

November 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations